PRESENTATION

H1 FY2024 — Results presentation

H1 FY2024PDF · 72 pages4.2 MB
Unaudited Results
and cash dividend declaration for the
six months ended December 2023

-- 1 of 72 --

2
Performance overview
Normalised
operating profit
+13%
to R5 622m
New business
+28%
to R14 197m
Discovery Insure	
Discovery Life	
Discovery Invest	
Discovery Bank	
Discovery Health
Vitality Health	
Vitality Life
USA
Headline
earnings
+0%
to R3 260m
Normalised
headline earnings
+11%
to R3 320m

-- 2 of 72 --

3
Navigating a complex backdrop
1 Sources: StatsSA, Statista, Office for National Statistics, US Bureau of Labor Statistics
2 Source: Bank of International Settlements
Slowing inflation globally High interest rates Market outlook
-2%
0%
2%
4%
6%
8%
10%
12%
Jun-20	
Oct-20	
Feb-21	
Jun-21	
Oct-21	
Feb-22	
Jun-22	
Oct-22	
Feb-23	
Jun-23	
Oct-23
United States South Africa
China United Kingdom
Inflation rate by market1 Central bank policy rates2
0%
1%
2%
3%
4%
5%
6%
7%
8%
9%
Jul-20	
Oct-20	
Jan-21	
Apr-21	
Jul-21	
Oct-21	
Jan-22	
Apr-22	
Jul-22	
Oct-22	
Jan-23	
Apr-23	
Jul-23	
Oct-23
South Africa United Kingdom
China United States
South Africa
• NHI bill has noble aims but creates uncertainty
• Election permutations create uncertainty
• Widespread power cuts have lessened
• Building a perfect composite model, number 1 in every
industry, along with supporting universal health
coverage for all in South Africa
United Kingdom
• NHS challenges persist
• High services price inflation continues to keep core
inflation elevated
• Building a new generation life and health insurer,
particularly on the back of a complex NHS environment
for the latter
China
• Relationship with the West remains strained
• GDP growth is anticipated to remain below its 5% target
• Economy is still struggling with deflationary pressures,
keeping inflation far below its 3% target
• Scaling Ping An Health Insurance in a complex Chinese
market
United States
• Economic growth expected to slow in 2024 due to
increased unemployment and fading post-pandemic
tailwinds
• Polarised elections raise economic uncertainty
• Globalising our unique assets

-- 3 of 72 --

4
Well positioned for growth in the micro-environment
Nature of
risk
Technology
Social
responsibility
Demographic
• Risk due to modifiable behaviours: 37% of
healthcare expenses are due to modifiable
behaviours
• Causality of behaviour change: mortality,
sickness and healthcare costs are significantly
impacted by behaviour change. This impact is
universal; it holds across age, gender, and
health status; and is elastic - so even more
significant for people who are older and sicker
Nature of risk
Demographic
Technology
Social responsibility
• Ageing populations impact on healthcare: there
is a corresponding rise in the incidence of chronic
diseases as populations age, leading to a surge in
healthcare expenses. Ageing demographics also
contribute to a growing demand for long-term
care services, further straining financial resources
• Heightened obesity levels: obesity rates are
increasing and the impact on healthcare costs is
substantial
• Artificial intelligence and machine learning
advances: new tools are revolutionising
diagnostics, treatment planning, and patient
care
• Benefits and costs of drug innovations: rapid
advances in areas like precision medicine,
targeted therapies and advanced
pharmaceuticals like GLP-1s bring promising
breakthroughs, yet the costs associated
contribute to the overall financial burden on
healthcare systems
• Stakeholder needs are more widely
defined: businesses face pressure to create
value for all stakeholders through their
products, services and client journeys
• Evolution of value-based care: accelerated
pressure on stakeholders to improve quality
of care and decrease costs, through a
patient-centric approach
This requires a deep understanding of
risk and how to manage it
This requires preventative measures,
interventions and disease management
programmes to improve population health
This requires sophisticated analytics to
deliver hyper-personalised solutions
This requires a shared-value business
model

-- 4 of 72 --

5
Period under review
1
2
3
Strong financial performance with robust operating profit growth, good
cash generation and capital resilience
A smooth transition to IFRS 17 accounting standard
A focused approach to create growth platforms by scaling the Bank,
evolving the Vitality Shared-value model and streamlining New initiatives
to embed significant growth potential into the Group
Ensuring Discovery SA, Vitality UK, and Vitality Global, and their
underlying businesses, are market leaders and performing optimally	4

-- 5 of 72 --

6
Growth and performance
Operating profit New business

-- 6 of 72 --

7
Strong operating performance
Operating profit
+13%
R5 622m
New business2
+28%
R14 197m
Non-insurance
income
+15%
R2 942m
ZARm
Health 1 874 +7% 6 835 +52% 592 +3%
Life – Individual 2 128 +12% 1 444 +7%
Life – Group 139 -42% 75 -42%
Invest 620 +11% 1 629 +8%
Insure 20 +150% 666 +8%
Bank -339 -15% 933 +32%
Other SA1 -87 +12% 451 -13%
SA composite 4 355 +9% 11 100 +29% 1 525 +19%
VitalityHealth 527 -20% 1 135 +28%
VitalityLife 390 +97% 935 +17%
VitalityInvest -57 -48%
Other initiatives and central costs -48 +85%
UK composite 812 +13% 2 070 +22%
Vitality Network 296 +49% 942 +25%
VHI – Ping An Health Insurance 344 +305% 1 0273 +28%
VHI – Other and central costs -185 +928% 475 -8%
VG composite 455 +71% 1 027 +28% 1 417 +11%
1 Vitality, Other SA Initiatives and Group initiatives and central costs	
3 PAHI own licence	
2 Excl products in run down
New business boosted by successful take-on of Sasolmed
Strong earnings and improving new business margins
Declined off prior period’s exceptional performance
Benefited from higher market levels
Increased demand from backlogs in NHS drove higher
new business, along with an increase in claims experience
Earnings increased from higher interest rates and once-
off variances, VNB margins under pressure
Strong growth and margin expansion
Excellent operating metrics, new business exceeded
expectation
Profit curtailed by two severe weather events
Continued investment into VHI
Achieved operational break-even on a monthly basis,
excellent performance across all metrics

-- 7 of 72 --

8
-
2,000
4,000
6,000
8,000
10,000
12,000
14,000
16,000
H1 2003	
H1 2004	
H1 2005	
H1 2006	
H1 2007	
H1 2008	
H1 2009	
H1 2010	
H1 2011	
H1 2012	
H1 2013	
H1 2014	
H1 2015	
H1 2016	
H1 2017	
H1 2018	
H1 2019	
H1 2020	
H1 2021	
H1 2022	
H1 2023	
H1 2024
Significant operating profit and new business growth over time
Operating profit New business
IFRS 4 IFRS 17
0
1,000
2,000
3,000
4,000
5,000
6,000
H1 2003	
H1 2004	
H1 2005	
H1 2006	
H1 2007	
H1 2008	
H1 2009	
H1 2010	
H1 2011	
H1 2012	
H1 2013	
H1 2014	
H1 2015	
H1 2016	
H1 2017	
H1 2018	
H1 2019	
H1 2020	
H1 2021	
H1 2022	
H1 2023	
H1 2024
Rapid growth in
IFRS 4 earnings
historically,
relatively flat on
transition, and
positioned for
growth going
forward
Operating profit New business
+13% +28%
New business
excluding
Discovery Health
+11%

-- 8 of 72 --

9
0%
20%
40%
60%
80%
100%
FY19	
H1 20	
FY20	
H1 21	
FY21	
H1 22	
FY22	
H1 23	
FY23	
H1 24
Group well capitalised with robust cash generation
DHMS solvency
(unaudited) 30.6%
1 Capital Adequacy Ratio
2 Comprehensive Solvency Ratio, definition set by China Banking and Insurance Regulatory Commission
3 Considers cash at centre, Discovery Life, Discovery Insure, VitalityHealth, VitalityLife and Discovery Bank
4 Centre cash + undrawn committed facilities
5 FY 2022 excludes life COVID claims net of financing
FLR within target
14%
16%
18%
20%
22%
24%
26%
28%
30%
FY 22 H1 23 FY 23 H1 24
0% CSM 50% CSM
100% CSM
28%
24%
20%
17%
FLR
Highly liquid across
the Group
Liquid assets across the
Group3, Rm
-
2,000
4,000
6,000
8,000
10,000
12,000
14,000
16,000
18,000
20,000
H1 21
FY21
H1 22
FY22
H1 23
FY23
H1 24
Strongly
capitalised
Dec 22
Cover
Dec 23
Cover
Life 1.8x 1.8x
Insure 1.4x 1.5x
VH 1.5x 1.4x
VL 2.2x 2.3x
Bank1 1.2x 1.3x
PAHI2 2.7x 3.1x
Strong cash
conversion
Group cash conversion5
COVID and
investment
in New
66%
Sufficient centre
liquidity
Centre liquidity4, Rm
-
500
1,000
1,500
2,000
2,500
3,000
H1 21 H1 22 H1 23 H1 24
R2.6bnR17.9bn

-- 9 of 72 --

10
Strong growth in Group Embedded Value
Opening EV Value of new
business
Unwind of risk
discount rate
Non-economic
experience
variances and
methodology
& assumption
changes
Operational EV Economic
experience
variances and
methodology
& assumption
changes
Forex New Initiatives Other IFRS 17
Transition
Impact
Closing EV
12.1%
Annualised RoEV
R105 251m
R98 176m
R103 480m

-- 10 of 72 --

11
IFRS 17 performance H1 FY23 to H1 FY24
R million
Actual Actual
%	H1 2024 H1 2023
Normalised profit from operations 5 622 4 973 +13%
Forex losses/gains -40 28
1 DP finance lease impact -59 -73
Finance charges excl. 1DP finance lease -881 -778
Investment income and fair value gains on financial instruments 195 132
Other -72 -50
Profit before fair value gains on VL swaption 4 765 4 232 +13%
Fair value gains on VL swaption - 391
Profit before tax 4 765 4 623 +3%
Taxation -1 422 -1 385
Profit after tax 3 343 3 238 +3%
Profit not attributable to ordinary shareholders -89 - 31
loss on impairment and derecognition of assets net of tax 6 69
Headline earnings 3 260 3 276 0%
Amortisation of intangibles from business combinations, net of tax 45 39
Economic assumptions adjustment - VL - -311
Restructuring costs 15 -
Normalised headline earnings 3 320 3 004 +11%
The prior reporting period includes a
considerable fair value gain from the
swaption, which was realised towards the
end of the previous financial year

-- 11 of 72 --

12
Dividend policy
Previously communicated at FY23 announcement:
Annual ordinary dividend is expected
to be covered approximately 5 times
by normalised headline earnings
Interim ordinary dividends expected
to be paid in the range of 30%-40% of
the expected total annual ordinary
dividend, with the remainder of the
dividend to be paid as a final dividend
The Group has declared
its interim ordinary
dividends for period at
65
cents per share

-- 12 of 72 --

13
Transition to IFRS 17

-- 13 of 72 --

14
Recap of IFRS 17 key messages
No change in underlying value nor
underlying economics
• No direct change to cash flows,
underlying risk and reward of
contracts. Tax cash flow impact
expected to be immaterial
• No impact on regulatory or
economic solvency, capital
position or capital management
• Immaterial impact on Embedded
Value
• Ability to pay dividend unaffected
as cash flows and solvency
remain unchanged
Accounting standard change that
affects the timing of profit
recognition, therefore affects
transitional balance sheet
1
2
IFRS 4
IFRS 17
Duration
Annual p
rofit
Discovery Life	
Vitality Life
Group is approaching cross-over	Value unchanged but reallocated
IFRS 4 IFRS 17
0
1,000
2,000
3,000
4,000
5,000
6,000
H1 2003	
H1 2005	
H1 2007	
H1 2009	
H1 2011	
H1 2013	
H1 2015	
H1 2017	
H1 2019	
H1 2021	
H1 2023
Strong IFRS 4 profit growth

-- 14 of 72 --

15
Life 2 518 2 145 -15%
Invest 592 561 -5%
VitalityHealth 867 658 -24%
VitalityLife 536 198 -63%
Other 1 417 1 411 0%
Total 5 930 4 973 -16%
H1 2023 restated from IFRS 4 to IFRS 17
Reconciliation of comparative period from IFRS 4 to IFRS 17
Rm
£10m (R204m) reduction in FinRe payments in
the H1 2023 emerged as profit under IFRS 4.
Under IFRS 17 this value would effectively have
been reflected in previous reporting periods,
which is included in the reported net asset value
£18m (R373m) of premium indexation in the prior
period due to higher rates of inflation, which
emerged as profit under IFRS 4. Under IFRS 17,
this value is presented in other comprehensive
income (OCI), which will emerge as profit in the
future
Difference between IFRS 4 and IFRS 17 is
volatile in the short-term
IFRS 4 IFRS 17 %
Life -3% -9%
Invest -26% -18%
VitalityHealth -111% -42%
VitalityLife -22% -43%
Other 1% 0%
Total -12% -14%
H2 2023 FY 2023
VitalityHealth’s FinRe impact
increased to £22.1m (R450m)
for FY 2023, widening the gap
between IFRS 4 and IFRS 17
H1 2023 earnings IFRS 4 vs IFRS 17 for H2 and FY 2023
IFRS 4 leads to a significant level of volatility that is reduced under IFRS 17 through the use of CSM and OCI
As at December 2023 the Group had R38.2bn of CSM net of reinsurance
H1 2023 benefited from lapse gains recognised
under IFRS 4 whilst deferred in CSM under IFRS
17. This difference narrowed materially over the
full restated prior reporting year to 30 June 2023
as the business progresses towards cross-over
Invest gap widens due to
positive cash flow and lapse
experience variances taken to
CSM under IFRS 17

-- 15 of 72 --

16
Business performance and Growth
platforms
Discovery Insure	
Discovery Life	
Discovery Invest	
Discovery Bank	
Discovery Health
Vitality Health	
Vitality Life
USA

-- 16 of 72 --

17
Discovery grows businesses organically
Organic growth
model
Focused on streamlining
New initiatives Growth platforms expected to drive material growth
Investment in New
% core operating profit
0%
5%
10%
15%
20%
25%
H1
2018
H1
2019
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
+ 10% to 15%
higher cash flow growth
GROWTH PLATFORMS
+ 5% to 10%
higher annual
operating profit growth
ESTABLISHED
EMERGING
NEW
Forward looking information on this slide is for illustration and has not been reviewed or reported on by the auditors
CPI+5%
CPI+30%
-10%
ESTABLISHED
BUSINESSES
GROWTH
PLATFORMS

-- 17 of 72 --

18
The Vitality chassis has evolved

-- 18 of 72 --

19
Vitality’s rich and comprehensive dataset allows for a sophisticated
understanding of behaviour and the impact on risk
Health
records
Incentives
Demographic
Wellness &
Behavioural
Mortality & healthcare
utilisation
Clinical
Financial
Risk
predictions	Diagnoses &
medication
Pathology &
radiology
Episodes of
care
Incentives
utilisation
habits
Response
to rewards
Incentive
partner
preferences
Age
Chronicity
Gender
Family
status
Location
Socio-economic
status Travel
Smoking
status
Vitality
age
HealthyFoods
Exercise &
Device data
Hospitalisations
Population
segmentation
Healthcare
claims & quality
Audited mortality
& causes
Debt
Retirement
savings
Transactions
Property
ownership
Savings
Data
science
Machine
learning
and AI
Vitality engagement | 26.5m life-years
Data from health checks and assessments, enrollment into Vitality
programs such as healthy weight and smoking cessation
Device data | 1.1bn events
All step and heartrate data gathered by devices from the
Vitality program
Wellness
Health utilisation | 48.7m life-years
Claim lines, hospital admissions, benefit details,
Demographic | 48.7m life-years
Member information, e.g. age, gender, health-related test
results, chronic conditions, and programs etc.
Conditions | 11.7m life-years
Chronic registrations, pathology results, health
related test results
Clinical
Clinical and wellness data
linked longitudinally
Using data from 2008 until 2024

-- 19 of 72 --

20
The effect of behaviour change exceeds expectations
Physical activity has a
significant impact on
mortality and increases by age
Physical activity has a significant
impact on healthcare costs
-29%
-52%
-59%
0 (base) Low Medium High
-36% -38%
-58%
0 (base) Low Medium High
Relative mortality for the 45-65 age group
Relative mortality for the 65+ age group
Relative reduction for the 45-65 age group
Relative reduction for the 65+ age group
-16%
-25%
No Habit
Strong poor
habit
Strong good
habit
-14%
-29%
No Habit
Strong poor
habit
Strong good
habit
No
habit
Strong poor
habit
Strong good
habit
No
habit
Strong poor
habit
Strong good
habit
Effects of behaviour change increase with
age and chronicity
Young moderately
healthy 30-year-old 10.2
56.7
43.5 53.7
Healthspan Sick years
10	46.7
Middle age unhealthy
50-year-old 10
.2
16.6 24.9
Healthspan Sick years
25.1
Advanced age
unhealthy 70-year-old 4
14.6
6.1 10.1
Healthspan Sick years
11.6
+7%
increase in
healthspan
+51%
increase in
healthspan
+90%
increase in
healthspan
8.3
33.5	8.4
3

-- 20 of 72 --

21
Vitality enhances the traditional value chain
UNDERWRITING PREMIUMS CLAIMS AND EXITS
TRADITIONAL
VALUE CHAIN
Underwriting Claims and
Exits
SHARED-VALUE
VALUE CHAIN
Dynamic Risk
Assessment
AI Recommender Incentivised
Engagement
Shared-value Pricing
Value Propensity Δ Habit Curated partner	
intervention network
Behaviour	
incentives
Hyperbolic discounting
Loss aversion
Over optimism
Premium	
archetypes	
Personalised	
mortality curves	
Fewer	
dimensions	
environment
Vitality wellness	
data
Devices + physical	
activity
Mental	
wellbeing
Behavioural
Claims	Nutrition data
Clinical data	
repository	
U/W data
Demographics
More	
dimensions	
environment
Full dimensions	
environment
Exercise	Healthy	
actions
Ranks the
top 3	
Next Best Actions
VALUE x PROPENSITY
 → HABIT
Get your HbA1c	
Take 5k	
Steps 2x	
Gym
Visit
Get Flu	
Vaccine
Heart
Rate
Workout
Get a	
mammogram
Visit
your PCP	
Complete	
VHC	
Park Run
Mental	
wellbeing	
assessment
Colon cancer	
screening
Visit your	
dentist
Healthy	
actions
HEALTHSPAN	
Effective years	
in perfect	
health
SICK
YEAR
S
Risk 1
LIFESPAN
Risk
2
Risk
5
Risk 6
Risk
3	
Ris
k 4
SICK YEARS	
HABIT
MORTALITY	
CURVES

-- 21 of 72 --

22
AI Recommender

-- 22 of 72 --

23
Hyper-personalised Next Best Actions, with personalised goals
VALUE PROPENSITY HABIT
Causal model built to estimate the
effect of completing an NBA on
downstream healthcare costs
Ensemble Machine Learning model
built to estimate the probability of a
customer to complete an NBA
Index built to quantify and classify a
customer's consistency of completing
an NBA
Get your HbA1c
Get Flu Vaccine
Visit your PCP
Complete VHC
Get Flu Vaccine
Get your HbA1c
Visit your PCP
Complete VHC
Get your HbA1c
Get Flu Vaccine
Visit your PCP
Complete VHC
Weak Bad
Strong Good
Weak Good
Strong Bad
Take 5k Steps 2x
Heart Rate Workout
Gym Visit
Park Run
Strong Good
Weak Good
Strong Bad
Weak Bad
Heart Rate Workout
Take 5k Steps 2x
Gym Visit
Park Run
Take 5k Steps 2x
Gym Visit
Heart Rate Workout
Park Run

-- 23 of 72 --

24
Personal Health Pathways | A hyper-personalised programme
manifesting in a simple user experience with two rings
Wearables/IoT Mobile
Activity
General
Engagement Assessments Screenings Underwriting
Data
Data Dimensions
Claims Hospital
Experience
Member
Information
Data Sources Personal Health Pathway
Dynamic Risk Assessment Next Best Action
Exercise	Healthy
actions
VALUE
 
PROPENSITY
Mortality
curves
HEALTHSPAN
Effective years in perfect
health
SICK
YEARS	Risk 1
LIFESPAN
Risk 2
Risk 5	
Risk 6
 
Risk 3
Risk 4
SICK YEARS
Risk 1 Risk 2
Risk 5	
Risk 6
 
Risk 3
Risk 4 Healthy
actions
Habit
Applicable to:
• Vitality
Network
• VHI
• Discovery
Health
• Discovery Life
• VitalityHealth
• VitalityLife
In future, Bank
and Insure

-- 24 of 72 --

25
Life insurer | The impact is significant on all measures
12%
higher VoNB
100%
104%
112%
90%
95%
100%
105%
110%
115%
Traditional
Insurer value
Higher VoNB
Customer value
Bronze
never pays
more than
traditional
Lower premiums
(PV premiums vs
Traditional, over 20yrs)
15%
more lives over
20 years
20
30
40
50
60
70
80
90
100
1 5 9 13 17 21 2529
Larger portfolio
of lives covered
Traditional
36%
more
engagement
25%
35%
45%
55%
65%
1 5 9 13 17 21 25 29
More health-
engaged
members
Value drivers of
Personal Health
Pathways
• Higher status
transitions
from
unengaged to
engaged
• Lower lapses
• Narrower risk
differentiation
within each
status
0%
20%
40%
60%
80%
100%
More rewards
(Vitality rewards as %
Vitality premiums)
18%
more Vitality
rewards
80
85
90
95
100
1 6 11 16 21 26
94%
Lower
premiums
Reduced cost of
cover
Traditional
Societal value
Bronze 99%
Silver 95%
Gold 81%
Platinum 81%
Vitality-integrated products
Vitality with Personal Health Pathways

-- 25 of 72 --

26
Health insurer | The impact is significant on all measures
Distribution of clients by healthcare costs Impact of doing Next Best Action | Net savings to health funder
Member base by different healthcare utilisation
scores
Healthcare utilisation score
Higher
Top 25% of clients within chronic cohorts with
highest
value x propensity to target with NBA
At-risk or unhealthy clients
Other
0%
20%
40%
60%
80%
100%
0% 25% 50% 75%
25% of
members
complete
NBA
58% of
potential
saving
Percentage completing NBA
Percentage saving
Distribution
Lower
Engagement
Diabetes
0%
20%
40%
60%
80%
100%
0% 25% 51% 76%
Hypertension Combined hypertension
and diabetes
0%
20%
40%
60%
80%
100%
0% 25% 51% 76%
Percentage completing NBA Percentage completing NBA
25% of
members
complete
NBA
25% of
members
complete
NBA
53% of
potential
saving
58% of
potential
saving

-- 26 of 72 --

27
Discovery Insure	
Discovery Life	
Discovery Invest	
Discovery Bank	
Discovery Health

-- 27 of 72 --

28
Discovery Bank
Clients Deposits Operating result	Revenue (NII + NIR)
+42% +31% -15%	+32%
to 825k to R16.67bn to (R339m)	to R933m
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
NII NIR
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
Loss before NBAC NBAC	Accounts	Clients
-40%
to (R154m)
Before NBAC
Advances
+20%
to R5.75bn
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024

-- 28 of 72 --

29
New business acquisition costs driven by strong growth
-
200
400
600
800
1 000
1 200
Jul-21	
Oct-21	
Jan-22	
Apr-22	
Jul-22	
Oct-22	
Jan-23	
Apr-23	
Jul-23	
Oct-23
Average daily sales Source of new business
New business
acquisition costs	New business product mix
>1 000
54%
0%
10%
20%
30%
40%
50%
60%
0 1 2 3 4+
New business by number of
Discovery products
Average July 2023 – December 2023
Product mix of new business
>40% Transaction Bundled
accounts, Credit cards and Suites
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Q1
FY22
Q2
FY22
Q3
FY22
Q4
FY22
Q1
FY23
Q2
FY23
Q3
FY23
Q4
FY23
Q1
FY24
Q2
FY24
Savings only Trans PAYT
Trans Bundled Credit & Suite
Average sales per business day
Jul-21	
Sep-21	
Nov-21	
Jan-22	
Mar-22	
May-22
Jul-22	
Sep-22	
Nov-22	
Jan-23	
Mar-23	
May-23
Jul-23	
Sep-23	
Nov-23
Average +10%
Average -10%
Average
New business acquisition costs per
new client

-- 29 of 72 --

30
Strong NIR growth
Spend is normalised for days in month.
Total net NIR
Increasing NIR per client by
duration
Record-high monthly
banking activity
H1
2021
H2
2021
H1
2022
H2
2022
H1
2023
H2
2023
H1
2024
38% CAGR
0%
50%
100%
150%
200%
250%
1 2 3 4 5 6 7 8 9 10 11 12
NIR per new client by months on book
(indexed to first month after joining)
Months on book
Monthly spend and payment volumes
Jul-21	
Sep-21	
Nov-21	
Jan-22	
Mar-22	
May-22
Jul-22	
Sep-22	
Nov-22	
Jan-23	
Mar-23	
May-23
Jul-23	
Sep-23	
Nov-23
Payment volumes
Normalised Spend
65% CAGR
58% CAGR
Rm

-- 30 of 72 --

31
Strong NIR growth driven by Banking capabilities
Make payment	Discover View class schedules Confirm booking	VITALITY
FITNESS
Pay using Vitality Pay,
Discovery Miles or a free credit
Confirm your spot at
the class in a few taps
Go through the facility’s class
schedule to find a suitable slot
Choose from >400
facilities in South Africa
VITALITY
TRAVEL
Make payment	Discover View flights Select flight
Pay using Discovery Miles or a
Discovery bank account
Select your flight and
confirm flight details
Go through the various flight
options with discounts applied
Select travel routes
and dates
Vitality Travel utilisation stats as at December 2023
>1.4m cumulative flights
booked since launch 2 338 members flying per
day with Vitality Travel >170k cumulative lounge
visits since launch

-- 31 of 72 --

32
High-quality credit growth strategy supported by the Shared-value
model and integration
Total NII Credit growth strategy Non-performing loans
Shared-value impact
and value of integration
0%
25%
50%
75%
100%
Q1 FY21	
Q2 FY21	
Q3 FY21	
Q4 FY21	
Q1 FY22	
Q2 FY22	
Q3 FY22	
Q4 FY22	
Q1 FY23	
Q2 FY23	
Q3 FY23	
Q4 FY23	
Q1 FY24	
Q2 FY24
ELR LR MR HR VHR
0%
20%
40%
60%
80%
100%
ELR
LR	
MR	
HR
VHR
-79%
Approval rate by credit risk
(indexed to exceptional low risk)
New business risk distribution
Credit loss ratio by Vitality Money
status
Risk distribution by DSY vs non-DSY
clients
0%
10%
20%
30%
40%
E ELR LR MR HR VHR
Discovery Non-Discovery
-2%
2%
6%
10%
J-22
M-22
M-22
J-22
S-22
N-22
J-23
M-23
M-23
J-23
S-23
N-23
Blue Bronze Silver
Gold Diamond
0%
1%
2%
3%
4%
5%
6%
7%
8%
9%
10%
11%
12%
13%
14%
A-21
O-21
D-21
F-22
A-22
J-22
A-22
O-22
D-22
F-23
A-23
J-23
A-23
O-23
D-23
Stage 3 (NPL) Stage 3 TTC average
Stage 3 average big four banks
Stage 3 advances
ELR: Exceptional low risk; LR: Low risk; MR: Medium risk; HR: High risk; VHR: Very high risk
H1
2021
H2
2021
H1
2022
H2
2022
H1
2023
H2
2023
H1
2024
45% CAGR
Rm

-- 32 of 72 --

33
Discovery Bank home loans market launch
Home loans mispricing is an
opportunity to create value
<-2.5% -2% --1.5% -1% -0.5% 0% 0.5% 1% 1.5% 2% 2.5% >3%
60%
Of Discovery
Bank clients
would get an
interest rate
reduction
Mispriced Discovery Bank clients
R280bnHome loan balances held by Discovery Bank clients
R1 400bn
Home loan balances held by South Africans
Interest rate saving calculated assuming an average interest rate of prime
The Discovery Bank Home Loan
New home loans,
switch or refinance
Dynamically
reduce interest
rate by up to 1%
Up to 100%
financing with
personalised
interest rates
Up to 30-year
term
Up to three co-
applicants

-- 33 of 72 --

34
Discovery Insure	
Discovery Life	
Discovery Invest	
Discovery Bank	
Discovery Health

-- 34 of 72 --

35
1993
1996
1999
2002	
2005	
2008
2011
2014
2017
2020	
2023
Non Scheme Products
Restricted Schemes
DHMS
Jan-18	
Jun-18	
Nov-18	
Apr-19	
Sep-19	
Feb-20	
Jul-20
Dec-20	
May-21	
Oct-21	
Mar-22	
Aug-22	
Jan-23	
Jun-23	
Nov-23
Flexicare Gap Cover
Healthy Company
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
Discovery Health
Operating profit & new business include Vitality Health International Africa
Operating profit New business Non-scheme growth	Membership
+7% +52% >3.8m
to R1 874m to R6 835m Lives under
administration Lives
>340k
Revenue
to R722m
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
Sasolmed closed scheme
+7% +17%

-- 35 of 72 --

36
Discovery Health Medical Scheme: continued excellent performance
in a complex environment
Membership and market share as at June 2023	
Plan changes exclude impact of plan closures
Membership Customer satisfaction Solvency
DHMS Rest of Industry
Others
57.8% market share
0%
2%
4%
6%
8%
10%
2019 2020 2021 2022 2023
Low proportions of members change plans, with
more members upgrading than downgrading:
Lapses continue to remain stable
R27.1bn
30.6%
AAA
unaudited reserves
unaudited solvency
credit rating
0%
5%
10%
15%
20%
25%
30%
35%
40%
-
5
10
15
20
25
30
35
2019 2020 2021 2022 2023
Reserve Actual Solvency
Required Solvency
R billion
0%
1%
2%
3%
2019-20 2020-21 2021-22 2022-23 2023-24
Upgrades Downgrades
96% no plan changes

-- 36 of 72 --

37
Significant value from introducing Personal Health Pathways
Chronicity
Ability to identify the most
valuable clients to target Significant uplift
Chronic ratios continue to increase
24%
26%
26%
27%
28%
22%
23%
24%
25%
26%
27%
28%
29%
2019 2020 2021 2022 2023
Members or clients living with chronic
disease are ~4X more expensive than
those without chronic disease
Members living
with diabetes
Members living
with hypertension
Combined effect
Base cost 25% complete NBA 50% complete NBA
Cost savings where Next Best Action
(NBA) is followed
58%
78%
53%
79%
58%
80%	Healthcare utilisation score
Higher
Top 25% of clients within chronic cohorts with
highest
value x propensity to target with NBA
At-risk or unhealthy clients
Other
Distribution
Lower

-- 37 of 72 --

38
A change to Section 33 is required to
enable private sector collaboration
“33. Once National Health Insurance has been fully
implemented as determined by the Minister through
regulations in the Gazette, medical schemes may
only offer complementary cover to services not
reimbursable by the Fund”
Discovery’s position: NHI is not
workable without private
sector collaboration
R200bn Additional funding required p.a, as indicated by the
National Department of Health for narrowed benefit
package
Healthcare funding available per person remains constrained (ZAR)
31% increase in personal income tax or;
6.5% increase in VAT (from 15% to 21.5%) or;
10x increase in payroll tax (current UIF contributions).
407
714
Current funding
for uncovered
lives
With additional
R200bn
2332
714
Current private
medical
schemes
Current NHI
proposal
– 69%
Public sector Private sector
NHI
Status quo is unsustainable – universal healthcare is crucial

-- 38 of 72 --

39
Discovery Insure	
Discovery Life	
Discovery Invest	
Discovery Bank	
Discovery Health

-- 39 of 72 --

40
IFRS 17
Discovery Life
Normalised
operating profit New business
Strong capital
and liquidity
+6% +2%
to R2 267m to R1 519m
Individual life:
+12%
SCR
coverage
Liquidity
coverage
2023 2023
180% R4 911m
1 X ILT
125%
SCR Target
Individual life :
+7%
12 months to
December 2023
Maintained leading
market share
Strong cashflow
generation
Life and Invest cash flow
in excess of 35% of net
of tax normalised earnings
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
Individual Group
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
Individual Group
Premium and Fees
Claims
Operational costs
Cashflows from existing
New business strain
Cashflows before FinRe
Net Finre
Net Cashflow
R771m
R2 841m
R10 427m
R1 093m
26.6%
2022 2023
27.5%
Discovery Life Market Share: +0.90% growth vs prior year, 1st and growing across IFA and Tied channels, negligible current share of bancassurance
NMG Market Share survey: Total Affluent Protection Market 2023

-- 40 of 72 --

41
Largely offsetting
Discovery Life Ltd variances (Rm):
Robust EV growth with positive operating variances
Life and Invest
Positive non-economic operating variances Growth in
Embedded Value
Jun-23 Dec-23
R41 138m
R42 863m
12% RoEV
R81m
0%
20%
40%
60%
80%
100%
120%
Mortality Morbidity Lapses
H1 2023 H1 2024
Individual life
Premium and fee income gain driven by positive integration
experience
Policy alterations was a significant negative variance and worsened
from prior period
15.3% constant economics
Improving claims experience,
with favourable mortality largely
offsetting elevated morbidity
Mortality and
morbidity	
Persistency
Premium and fee
income
Policy alterations
Other
Total Non-Economic
Economic
Total

-- 41 of 72 --

42
Margin improvement and generating significant customer value
Significant improvement in VNB margin
Individual life:
5.6% (IRR: 21.5%)
VNB Margin (%)
Increase in margin driven by:
• Strong new business volumes in Individual Life
• Improved business mix
• Efficient expense management
• Negative economic impact
Jun-23 Economic Unit
Expenses
Business Mix Dec-23
2.5%
4.3%
Individual life:
3.2% (IRR: 19.2%)
Superior returns driven by Shared-value model
c70% of value from behavioural uplift returned to policyholder
VNB per unit of premium*:
from Shared-
value model
1.8x times
*Based on June 2023 data and long-term interest rate view

-- 42 of 72 --

43
Discovery Insure	
Discovery Life	
Discovery Invest	
Discovery Bank	
Discovery Health

-- 43 of 72 --

44
IFRS 17
Discovery Invest
Normalised operating
profit New business
Assets under
administration
+11% +8% +11%
to R620m to R1 629m to R145bn
Dec-17
Jul-18
Feb-19	
Sep-19	
Apr-20	
Nov-20	
Jun-21	
Jan-22	
Aug-22	
Mar-23	
Oct-23
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
Cogence
Full executive team
in place
On track for R16bn
AUM in short-term
Fully integrated
Aladdin WealthTM
technology with
Vitality Healthy
Futures

-- 44 of 72 --

45
Discovery Insure	
Discovery Life	
Discovery Invest	
Discovery Bank	
Discovery Health

-- 45 of 72 --

46
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
Discovery Insure
Gross written
premium Gross new business
Normalised
operating profit	Vehicles insured
+9% +8% -92%	+1%
to R2.8bn to R666m to R2m	to 291 194
1 Personal lines figures only 2 Figures excluding VAT 3 Normalised operating profit includes Personal lines but excludes Cambridge Mobile Telematics (CMT), Sigfox and Bi-ME
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024

-- 46 of 72 --

47
FY
2018
FY
2019
FY
2020
FY
2021
FY
2022
FY
2023
H1
2024
FY
2018
FY
2019
FY
2020
FY
2021
FY
2022
FY
2023
H1
2024
Average claims cost increase
Average in-force premium increase
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
1 2 3 4 5 6 7 8 9 10 11 12 13
Duration on book
Good Average Bad Loss Ratio
Target loss
ratio
Pre-CAT loss
ratio
Actual loss
ratio
Insure well positioned to achieve target margin
Operating margin set back due to loss of pricing
power during COVID and extreme weather impacts Vitality allows for a unique business model
Best drivers receive value and
are less likely to lapse
17%
10%
9%
7%
0% 0%-5% 5%-10%
10%-15% 15%-20% 20%-25%
Proportion of good drivers increases over
time resulting in lower loss ratios
Gauteng hailstorm in November
2023 was the worst in Insure’s
history
R130.7m net impact of
extreme weather events
set margin recovery back
Distribution of drivers in 2023 relative to
duration of in-force policies
Average premium increases reflect
repricing strategies after COVID impact
58%
lower lapse rate
for same premium
increase
Lapse rate by VD status and
premium increases
COVID-19
Average
increase
+ 3%
Good drivers have a 36% lower loss ratio
than bad drivers
Average
increase
- 3%

-- 47 of 72 --

48
Vitality Health	
Vitality Life

-- 48 of 72 --

49
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
IFRS 17
UK Composite
Normalised
operating profit Earned premiums New business	Lives covered
-2% +11% +6%	+5%
to £34.7m to £536m to £88.3m	to 1.8m lives
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
GBP millions	
GBP millions	
GBP millions
+13%
to R812m
+27%
to R12.6bn
+22%
to R2.1bn
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
Both VH and VL
earnings impacted
by specific aspects in
the transition from
IFRS 4 to IFRS 17

-- 49 of 72 --

50
IFRS 17
VitalityHealth
Normalised
operating profit Earned premiums New business	Lives covered
-30% +11% +11%	+10%
to £22.5m to £339.4m to £48.4m	to 989k lives
GBP millions	
GBP millions
-20%
to R527m
+27%
to R8bn
+28%
to R1.1bn
GBP millions
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
Impact of
increased
claims
spend

-- 50 of 72 --

51
Dynamics of healthcare in the UK
NHS Digital: Referral to Treatment Waiting Times
UK Health Accounts 2022
Challenges in accessing treatment Material gearing effect for private healthcare
0
1
2
3
4
5
6
7
8
9
Jan-13	
Nov-13	
Sep-14
Jul-15
May-16	
Mar-17	
Jan-18	
Nov-18	
Sep-19	
Jul-20	
May-21	
Mar-22	
Jan-23	
Nov-23
NHS waiting list (millions)
7.6m
National Health System (NHS) waiting list
6.7
233
0
50
100
150
200
250
Private heathcare
expenditure
NHS budget
Healthcare expenditure (£bn)
c35x

-- 51 of 72 --

52
NHS backlogs resulting in increased utilisation with a shift to
primary care
Shift to primary care
Substantially increasing
benefit utilisation
Pricing actions
implemented
Impacting overall claims
experience
+18%
-9%
+7%
Claimants
per 1,000
lives
Cost per
claim
Claims
PLPM	
2015
2016
2017
2018
2019
2020
2021
2022
2023
Optical, Dental and Hearing
Physiotherapy
Talking Therapies
Vitality GP
2019	
2020	
2021	
2022	
2023
In-Hospital
Consultations
Consultant Procedures
Radiology
Pathology
Vitality GP
CBT
Physiotherapy
62%
Claims attributable to primary
care
Change in claims experience
(2022 vs 2023)	Vitality GP
+322%
CBT
+200%
Optical, dental
& hearing
+113%
Claims per 1 000 lives
>£25m impact
Claims increase vs average written
premium by renewal cohort
Jul-22	
Sep-22	
Nov-22	
Jan-23	
Mar-23	
May-23
Jul-23	
Sep-23	
Nov-23	
Jan-24
YoY increase in claims PLPM
YoY increase in 3m average premiums

-- 52 of 72 --

53
Excellent quality of the business positions it well for growth
1. LaingBuisson Health Cover Report (18th Edition)
Strong growth Resilient retention rates
Unique digital capabilities and
industry recognition
Individual and SME lapse rates Digital assets
4.9
4.3
Vitality GP app
rating
Vitality Trustpilot
score
-14%
2019
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
H1
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
3rd largest health insurer1

-- 53 of 72 --

54
IFRS 17
VitalityLife
Normalised
operating profit Earned premiums New business	Lives covered
+71% +10% +2%	+6%
to £16.6m to £196.7m to £39.9m	to 782k lives
GBP millions	
GBP millions	
GBP millions
+97%
to R390m
+26%
to R4.6bn
+17%
to R935m
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
Higher interest
income and
once-off
variances

-- 54 of 72 --

55
Embedding Shared-value in the PAC book
Causal impact of behaviour
change
Behavioural-based valuation
model
Shared-value modelling on PAC
book
£4.8m
Once-off uplift in value
Timing difference due to
Prudential FY end at December
Prudential adopted causal
inference and habit formation
Shared-value assumption
changes
Expect positive variances in
future as engagement increases
and habit formation continues
Isolating the impact of physical activity on
mortality after adjusting for confounding
factors
Death (𝑡2)
(Outcome)
Physical activity
points (𝑡1)
(Treatment)
Age
(𝑡0)
Vitality Status
(𝑡0)	Duration
on Vitality
Total Claims
(𝑡0)
RUB
(𝑡0)
Socio-
economic
score
(𝑡0)
Chronic
Count
(𝑡0)
PA Points per Week
(𝑡0)
Health Status Demographic	Physical activity
Differential assumptions and transitions
Mortality, morbidity, lapses
Bronze Silver Gold	Blue
Transitions No
activity
Bad /
Medium
activity
Good
activity
6-week habit
 Weak
habit
Weak
bad
Weak
good
Strong
bad
Strong
good
Strong
habit
Create habit
Increase
activity
level
Increase
activity
level
Create habit
1.
2.
3.
4.

-- 55 of 72 --

56
Positive lapse and claims experience, and offsetting impacts from
high interest rates
Positive experience
variances
High long-term interest
rates
Margins negatively
impacted
Strong indexation
results
Aug-2022	
Sep-2022	
Oct-2022	
Nov-2022	
Dec-2022	
Jan-2023	
Feb-2023	
Mar-2023	
Apr-2023	
May-2023	
Jun-2023
VNB margin (%)
95.5%
UK 50-year swap rate history1 Indexation continuation upon
policy anniversary
0%
1%
2%
3%
4%
5%
2019
Jan
2020
Jan
2021
Jan
2022
Jan
2023
Jan
2024
Jan
1. MarketWatch
2.Office for National Statistics: CPI
EV experience variances (£m)
£13.8m indexation
benefit to OCI
Measures being implemented
• Targeted growth in profitable segments
• Release of expense efficiencies
• Balance sheet optimisation
Consumer Price Inflation2
0%
4%
8%
12%
Jan-19	
Jun-19	
Nov-19	
Apr-20	
Sep-20	
Feb-21	
Jul-21	
Dec-21	
May-22	
Oct-22	
Mar-23	
Aug-23
2.09%
IRR above RFR
4.8
1.8
3.0
9.6
Premium
Income
Lapses &
CFIs
Mortality
and
Morbidity
Total

-- 56 of 72 --

57
USA

-- 57 of 72 --

58
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
Vitality Global
Vitality Global Operating result
Strong underlying growth, driven by deepened
partner relationships, broadening the reach of
Vitality assets and capabilities
Vitality
Network
Vitality Health
International +55%
to $24.4m
+71%
to R455m
USA
HEALTH

-- 58 of 72 --

59
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
Vitality Network
Integrated API by
insurance partners Revenue
Insurance partners
membership	Operating profit
+16%
to $806.7m
+25%
to R15.1bn
+16%
to $50.3m
+25%
to R941.5m
+37%
to $15.8m
+49%
to R295.8m
+28%
to 4.3m
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024

-- 59 of 72 --

60
Key strategic focus areas
1
Revenue growth through deepening of
existing insurance partnerships and
targeted pursuit of new insurance
partnerships, as well as starting to
participate in emerging profits
2 Unlock geared profits through operational
efficiency generated from scaling, South
Africa based back office and offshore
development centre
3 Evolving Vitality products driving greater
value
40
25
16
10
4 5
% Revenue (in USD)
Emphasis on
expansion within
the US Market
TATA AIA India
membership has grown
by 5.5x over the last
calendar year
+16% Revenue growth
from December ‘22
+37% Profit growth from
December ‘22
Revenue
Expenses
Significant mortality
improvements across markets
H1FY20 H1FY21 H1FY22 H1FY23 H1FY24
35.6m 33.6m
42.2m 43.5m
50.3m
34.5m
32.0m	33.5m
25.3m
31.2m

-- 60 of 72 --

61
USA
+96%
to $9.2m
+125%
to R171m
HEALTH
VHI
 - Other
 
VHI
 – PAHI
Including PAHI equity earnings
Vitality Health International
Vitality Health International Operating result
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
Driven largely by
growth in PAHI
Vitality USA continues to accelerate its development of its
technology platform, including the new Personal Health
Pathways product, with a robust pipeline of prospective sales
and strong growth in the rate of successful sales.
PAHI continues to be a resilient performer with the business
beginning to see a return on the investments made in
diversifying its distribution channels with 28% growth in new
business on PAHI licence for the period, despite a reduction in
PAL agency force. Total written premiums increased 14%,
growing 10% faster than the market average.
Continued strong progress in build-out of four cloud-native SaaS
solutions, with three key products already at deployment stage.
Increased sales traction and pipeline emerging in AIA markets
and with third party-clients in the region.
Revenue continues to be under pressure post the conclusion of
Covid government contracts. The business continues to pursue
opportunities to diversify its footprint both geographically and
across client segments, and is successfully implementing a best-
in-class data science platform with AI-driven personalised health
recommendations for Discovery Health SA, and similar
implementations for Vitality UK and Vitality US.

-- 61 of 72 --

62
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
PAHI licence Reinsurance
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
Investment income and gains
Profit before investment income
and gains
to RMB0.6bn
(RMB140m DSY’s
share)
1 100% of PAHI
PAHI’s operating
results pre-tax
Discovery’s operating
result after tax
PAHI licence new
business1	Written premium1
+126% +305% +28%	+14%
to R1.4bn
(R361m DSY’s
share)
to R344m to R4.1bn	to R23.3bn
Ping An Health Insurance
+17%
PAHI licence
written
premium
+117% +10%
to RMB9.0bn
+289%
to RMB133m
+23%
to RMB1.6bn
RMB millions	
RMB millions	
RMB millions	
RMB millions
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
Lives
0
5
10
15
20
25
30
Jun-19	
Dec-19	
Jun-20	
Dec-20	
Jun-21	
Dec-21	
Jun-22	
Dec-22	
Jun-23	
Dec-23
+34%
to 26m PAHI licence
lives
Millions
+34%

-- 62 of 72 --

63
Excellent operating performance
Increasing reapplication
rates
Better persistency Excellent quality
80%
82%
84%
86%
2021 2022 2023
Decreasing COR
Strong cash generation
-
1
2
3
4
2021 2022 2023
Billions
Net cashflow from operating
activities (RMB)
100%
95% 95%
91%
2020 2021 2022 2023
Balance sheet strength
0
1,000
2,000
3,000
4,000
5,000
6,000
7,000
8,000
9,000
10,000
2019 2020 2021 2022 2023
Net asset value RMBm as
at 31 December
RMB8.6bn

-- 63 of 72 --

64
Maintained superior profitability, building a comprehensive
business driven by health and wellness services
Maintained leading position in the market Developed meaningful health and wellness services
-8%
-6%
-4%
-2%
0%
2%
4%
6%
8%
10%
PAHI CPIC Health PICC Health
2018 2019 2020 2021 2022 2023 Q3
Net margin
Network arrangements
with hospitals
1st in China
Specialist health insurer
in terms of profit margin
2nd largest
Specialist health insurer
by premium
16th in China
In terms of net profit,
among all life, P&C and
health insurers
Providing health insurance products, ranging from basic affordable
cover to high-end comprehensive cover, to both the individual
market and the corporate market
16
provinces
26m
lives
242
outside of China
1 033
China

-- 64 of 72 --

65
Growth platforms

-- 65 of 72 --

66
Discovery grows businesses organically
Organic growth
model
Focused on streamlining
New initiatives Growth platforms expected to drive material growth
Investment in New
% core operating profit
0%
5%
10%
15%
20%
25%
H1
2018
H1
2019
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
+ 10% to 15%
higher cash flow growth
GROWTH PLATFORMS
+ 5% to 10%
higher annual
operating profit growth
ESTABLISHED
EMERGING
NEW
Forward looking information on this slide is for illustration and has not been reviewed or reported on by the auditors
CPI+5%
CPI+30%
-10%
ESTABLISHED
BUSINESSES
GROWTH
PLATFORMS

-- 66 of 72 --

67
Growth platforms expected to drive material growth
FY20 FY21 FY22 FY23 FY24 FY25 FY26 FY27 FY28
Operating profit
10% to 15%
higher from Growth platforms
Long-term cash flow growth CAGR
Established
businesses only
Established
businesses +
Growth platforms
CPI+[10% to 15%]
annual growth
Economics of the Growth platforms
Forward looking information on this slide is for illustration and has not been reviewed or reported on by the auditors

-- 67 of 72 --

68
Bringing the Bank to scale and profitability in the near-term
−
R172m R170m R35mFeb
2024
Operating income Expenses New business
acquisition costs Profit / (loss) before tax	− =
15% to 20% -10% to 0% -5% to 5% 65% to 75%
Medium-term real growth targets
Jul-23
Nov-23	
Mar-24
Jul-24
Nov-24	
Mar-25
Jul-25
Nov-25	
Mar-26
Jul-26
Nov-26	
Mar-27
Jul'23 projected profit (loss) before NBAC
Actual profit (loss) before NBAC
Jul'23 projected profit (loss) after NBAC
Normalised operating expenses (Rm) NBAC per new client (R) Profit (Loss) before tax
Forecast
NII +NIR (Rm)
J-23
N-23
M-24
J-24
N-24
M-25
J-25
N-25
M-26
J-26
N-26
M-27
0
200
400
600
800
1000
1200
1400
1600
1800
Jul-21	
Oct-21	
Jan-22	
Apr-22	
Jul-22	
Oct-22	
Jan-23	
Apr-23	
Jul-23	
Oct-23
0
20
40
60
80
100
120
140
160
Jul-21	
Oct-21	
Jan-22	
Apr-22	
Jul-22	
Oct-22	
Jan-23	
Apr-23	
Jul-23	
Oct-23
 -
20
40
60
80
100
120
140
160
Jul-21	
Oct-21	
Jan-22	
Apr-22	
Jul-22	
Oct-22	
Jan-23	
Apr-23	
Jul-23	
Oct-23
− −
2% CAGR	60% CAGR 1% CAGR
R933m R1 097m R185mH1
FY24 − −
Forward looking information on this slide is for illustration and has not been reviewed or reported on by the auditors

-- 68 of 72 --

69
Vitality Network unlocking operational efficiencies
Vitality Network
global partners
Gearing effect due to growing foreign currency revenues and stable ZAR-
based expenses
+16% USD revenue growth
from December 2022
Revenue
Strong sales, increasing membership
and revenue growth in Asia
+8% Expense growth from
December 2022
Expenses
Flat US dollar cost base, given the
cost bias to South African rands
+37% USD profit growth from
December 2022
Normalised operating profit
Robust revenue growth and continued
expansion of the profit margin
H1FY20 H1FY21 H1FY22 H1FY23 H1FY24 H1FY20 H1FY21 H1FY22 H1FY23 H1FY24
4.4m
8.2m 8.6m
11.5m
15.8m
34.5m
32.0m	33.5m
25.3m
31.2m
35.6m
33.6m
42.2m
43.5m
50.3m Revenue
Expenses
Profit
Operational efficiencies ($m)
3.6x

-- 69 of 72 --

70
Expect Ping An Health Insurance to continue growing strongly
Growing lives
0
5
10
15
20
25
30
Jun-19	
Dec-19	
Jun-20	
Dec-20	
Jun-21	
Dec-21	
Jun-22	
Dec-22	
Jun-23	
Dec-23
+34%
Excellent quality
COR
Strong cash
generation
-
1
2
3
2021 2022 2023
Billions
Net cashflow from
operating activities
H1
2020
H1
2021
H1
2022
H1
2023
H1
2024
Rising written
premium1
RMB millions
1 100% of PAHI
0
1,000
2,000
3,000
4,000
5,000
6,000
7,000
8,000
9,000
10,000
2019 2020 2021 2022 2023
as at 31 December 2023
100%
95% 95%
91%
2020 2021 2022 2023
Increasing NAV
to 26m y-o-y
+14%
to R23.3bn
91% R8.1bn
RMB
Net Asset Value
 RMBm
R22.5bn
3.06x Comprehensive
solvency ratio

-- 70 of 72 --

71
Period under review
1
2
3
No material impact on
underlying economic value,
solvency levels or cash flows,
but affected the incidence of
profit recognition
Strong financial performance with robust operating
profit growth, good cash generation and capital
resilience
A smooth transition to IFRS 17 accounting standard
A focused approach to create growth platforms by
scaling the Bank, evolving the Vitality Shared-value
model, and streamlining New initiatives to embed
significant growth potential into the Group
Ensuring Discovery SA, Vitality UK, and Vitality
Global, and their underlying businesses, are market
leaders and performing optimally
4
Normalised
operating profit
+13%
New
business
+28%
FLR
20%
Cash
conversion
66%
+ [10% to 15%]
higher cash flow growth
+ [5% to 10%]
higher annual operating
profit growth
GLOBAL +9%
+13%
+71%
Operating
profit
New
business
+29%
+22%
+28%
Total Group
CSM
R38.2bn

-- 71 of 72 --

Unaudited Results
and cash dividend declaration for the
six months ended December 2023

-- 72 of 72 --